{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:17:35Z","timestamp":1787822255402,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20210430"],"award-info":[{"award-number":["BK20210430"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773827"],"award-info":[{"award-number":["81773827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304642"],"award-info":[{"award-number":["82304642"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2018GY33"],"award-info":[{"award-number":["CPU2018GY33"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M681786"],"award-info":[{"award-number":["2020M681786"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cbi.2024.111364","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:17:25Z","timestamp":1735060645000},"page":"111364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice"],"prefix":"10.1016","volume":"406","author":[{"given":"Qian","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninglin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongmi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-0822","authenticated-orcid":false,"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cbi.2024.111364_bib1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.cbi.2024.111364_bib2","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.14309\/ajg.0000000000000268","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis","volume":"114","author":"Yokoda","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/17512433.2015.1092381","article-title":"Obeticholic acid for the treatment of primary biliary cirrhosis","volume":"9","author":"Trivedi","year":"2016","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"9972","key":"10.1016\/j.cbi.2024.111364_bib4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for noncirrhotic, nonalcoholic steatohepatitis (FLINT): a multicenter, randomized, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cbi.2024.111364_bib5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111364_bib39","unstructured":"FDA. Warning: hepatic decompensation and failure in primary biliary cholangitis patients with cirrhosis. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207999s008lbl.pdf."},{"key":"10.1016\/j.cbi.2024.111364_bib38","unstructured":"FDA warns about serious liver injury with Ocaliva (obeticholic acid) for rare chronic liver disease. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-liver-injury-ocaliva-obeticholic-acid-rare."},{"issue":"4","key":"10.1016\/j.cbi.2024.111364_bib6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/hep.31017","article-title":"Liver injury in patients with cholestatic liver disease treated with obeticholic acid","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cbi.2024.111364_bib7","article-title":"Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis","volume":"1865","author":"Carino","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2024.111364_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33070-1","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis","volume":"8","author":"van Golen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111364_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120882","article-title":"Obeticholic acid aggravates liver injury by upregulating the liver expression of osteopontin in obstructive cholestasis","volume":"307","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2024.111364_bib10","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"15","key":"10.1016\/j.cbi.2024.111364_bib11","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1074\/jbc.275.15.10918","article-title":"Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription","volume":"275","author":"Chiang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"9 Pt B","key":"10.1016\/j.cbi.2024.111364_bib12","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bbadis.2018.06.003","article-title":"Interaction of glucocorticoids with FXR\/FGF19\/FGF21-mediated ileum-liver crosstalk","volume":"1864","author":"Al-Aqil","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.cbi.2024.111364_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116638","article-title":"Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats","volume":"232","author":"Duan","year":"2019","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.cbi.2024.111364_bib14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metabol."},{"issue":"2","key":"10.1016\/j.cbi.2024.111364_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcmgh.2022.04.011","article-title":"Hepatic SIRT6 modulates transcriptional activities of FXR to alleviate acetaminophen-induced hepatotoxicity","volume":"14","author":"Liu","year":"2022","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.cbi.2024.111364_bib16","article-title":"Effects of intestinal FXR-related molecules on intestinal mucosal barriers in biliary tract obstruction","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.cbi.2024.111364_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jceh.2021.11.004","article-title":"Value of liver function tests in cirrhosis","volume":"12","author":"Sharma","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"10.1016\/j.cbi.2024.111364_bib18","first-page":"467","article-title":"High promoter activity of cytokeratin-19 gene in cholangiocarcinoma","volume":"9","author":"Qin","year":"2018","journal-title":"Mol Clin Oncol"},{"issue":"10","key":"10.1016\/j.cbi.2024.111364_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102464","article-title":"Obeticholic acid for primary biliary cholangitis","volume":"10","author":"Floreani","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cbi.2024.111364_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.510230312","article-title":"Identification of bipotential progenitor cells in human liver development","volume":"23","author":"Haruna","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cbi.2024.111364_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.cbi.2024.111364_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","article-title":"FXR modulators for enterohepatic and metabolic diseases","volume":"28","author":"Wang","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"issue":"7","key":"10.1016\/j.cbi.2024.111364_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molmed.2007.06.001","article-title":"Targeting farnesoid X receptor for liver and metabolic disorders","volume":"13","author":"Fiorucci","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib24","first-page":"1863","article-title":"Beneficial effect of resveratrol on alpha-naphthyl isothiocyanate-induced cholestasis via regulation of the FXR pathway","volume":"17","author":"Ding","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"22","key":"10.1016\/j.cbi.2024.111364_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213967","article-title":"The farnesoid X receptor as a master regulator of hepatotoxicity","volume":"23","author":"Rausch","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cbi.2024.111364_bib26","article-title":"Aging Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH","volume":"8","author":"Bjursell","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cbi.2024.111364_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/toxsci\/kfab027","article-title":"FXR-deoxycholic acid-TNF-alpha Axis modulates acetaminophen-induced hepatotoxicity","volume":"181","author":"Yan","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Stephen","year":"2021","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cbi.2024.111364_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP Axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cbi.2024.111364_bib30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00204-022-03266-6","article-title":"Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR\/SHP pathway","volume":"96","author":"Zhang","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.14020","article-title":"Advantages and disadvantages of apoptosis in the aging process","volume":"1443","author":"Arguelles","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41418-018-0108-5","article-title":"The cisd gene family regulates physiological germline apoptosis through ced-13 and the canonical cell death pathway in Caenorhabditis elegans","volume":"26","author":"King","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2024.111364_bib33","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"Hu","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cbi.2024.111364_bib34","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.cdd.4400714","article-title":"Bcl-2 and Bax mammalian regulators of apoptosis are functional in Drosophila","volume":"7","author":"Gaumer","year":"2000","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cbi.2024.111364_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.cbi.2024.111364_bib36","article-title":"DNA damage-how and why we age","volume":"29","author":"Yousefzadeh","year":"2021","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.cbi.2024.111364_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111364_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ebiom.2018.10.028","article-title":"Noncanonical farnesoid X receptor signaling inhibits apoptosis and impedes liver fibrosis","volume":"37","author":"Wang","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724005106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724005106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:48:45Z","timestamp":1736804925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724005106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0009279724005106"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111364","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111364"}}